Clinical Trial Update: Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone [Phase 4]

View source ↗

Summary

This clinical trial update notes that a Phase 4 study of XGEVA (denosumab) in Chinese adults and skeletally mature adolescents with giant cell tumor of the bone…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Xgeva (denosumab)

Snippet

Sponsor: Amgen | Conditions: Giant Cell Tumor of Bone | Phase 4 | Status: ACTIVE_NOT_RECRUITING